Braveheart Bio jumps 68% in trading debut after $383M IPO
Posted On August 7, 2026
Braveheart Bio’s IPO success highlights strong investor appetite for biotech innovation, despite risks of high valuations without revenue.
The post Braveheart Bio jumps 68% in trading debut after $383M IPO appeared first on Crypto Briefing.
About The Author
